Your browser doesn't support javascript.
loading
30-Second Chair Stand and 5-Times Sit-to-Stand Tests Are Interesting Tools for Assessing Disability and Ability to Ambulate among Patients with Multiple Sclerosis.
Polidori, Andrea; Malagoli, Mattia; Giacalone, Rosario; Brichetto, Giampaolo; Monti Bragadin, Margherita; Prada, Valeria.
Afiliación
  • Polidori A; Scientific Research Area, Fondazione Italiana Sclerosi Multipla (FISM), 16149 Genova, Italy.
  • Malagoli M; Servizio Riabilitazione Liguria, Associazione Italiana Sclerosi Multipla (AISM), 16149 Genova, Italy.
  • Giacalone R; Servizio Riabilitazione Liguria, Associazione Italiana Sclerosi Multipla (AISM), 16149 Genova, Italy.
  • Brichetto G; Scientific Research Area, Fondazione Italiana Sclerosi Multipla (FISM), 16149 Genova, Italy.
  • Monti Bragadin M; Scientific Research Area, Fondazione Italiana Sclerosi Multipla (FISM), 16149 Genova, Italy.
  • Prada V; Scientific Research Area, Fondazione Italiana Sclerosi Multipla (FISM), 16149 Genova, Italy.
Life (Basel) ; 14(6)2024 May 30.
Article en En | MEDLINE | ID: mdl-38929686
ABSTRACT
Multiple Sclerosis (MS) is a demyelinating and chronic disease with variable neurological symptoms. There are different scales that score the level of disability, but only few papers have taken into consideration the 5-times sit-to-stand (5STS) test and the 30 s chair stand test (30CST), which are valid and easily obtainable indicators of other neurological diseases. The aim of our research is to verify the validity, reproducibility, and responsiveness of these tests. Patients afflicted with MS were enrolled in the AISM outpatient facility. The inclusion criterion was an EDSS score less than 6.5. We performed the 5STS, 30CST, and timed 25-foot walk (T25-FW) tests and recorded EDSS scores in the first evaluation. Then, we recorded the performance after 5 days (conducted by a second blind operator to ensure test-retest reproducibility), and the last evaluation was made after 12 sessions of physiotherapy. We recruited 38 patients diagnosed with MS. The results show significant data regarding validity, reproducibility, and responsiveness for both scales. The data argue in favor of adding these tests to the relevant clinical assessments. These two tests are simple, reliable, and easy to administer, and the data confirm that they can be included in the evaluation of patients with MS.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Life (Basel) Año: 2024 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Life (Basel) Año: 2024 Tipo del documento: Article País de afiliación: Italia